Erythropoietin treatment in metastatic breast cancer--effects on Hb, quality of life and need for transfusion.

Anna-Maria Olsson, Jan-Henry Svensson, Judit Sundström, Stefan Bergström, Thomas Edekling, Göran Carlsson, Jörgen Hansen, Birgitta Svensson, Maria Albertsson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)517-524
JournalActa Oncologica
Volume41
Issue number6
DOIs
Publication statusPublished - 2002

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Oncology, Malmö (ceased) (LUR000015), Oncology, MV (013035000)

Subject classification (UKÄ)

  • Cancer and Oncology

Free keywords

  • Female
  • Hemoglobins: analysis
  • Human
  • Middle Age
  • Neoplasm Metastasis
  • Quality of Life
  • Support
  • Erythropoietin: administration & dosage
  • Breast Neoplasms: pathology
  • Blood Transfusion
  • Anemia: therapy
  • Anemia: etiology
  • Anemia: blood
  • 80 and over
  • Adult
  • Aged
  • Non-U.S. Gov't

Cite this